Skip to main content
GlaxoSmithKline PLC logo

GlaxoSmithKline PLC — Investor Relations & Filings

Ticker · GSK ISIN · GB00BN7SWP63 LEI · 5493000HZTVUYLO1D793 IL Manufacturing
Open in API
Filings indexed 7,020 across all filing types
Latest filing 2025-09-30 Regulatory Filings
Country GB United Kingdom
Listing IL GSK

About GlaxoSmithKline PLC

https://www.gsk.com/en-gb/

GSK plc is a global biopharmaceutical company that unites science, technology, and talent to research, develop, and manufacture medicines and vaccines. The company focuses on preventing and treating disease across four primary therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. Its portfolio consists of specialty medicines and vaccines aimed at addressing significant global health needs. GSK's strategy centers on leveraging its research and development capabilities to deliver new health solutions.

Recent filings

Filing Released Lang Actions
GSK - THIRD TRANCHE OF SHARE BUYBACK PROGRAMME
Regulatory Filings
2025-09-30 English
GSK - third tranche of share buyback programme
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from GSK plc regarding the commencement of the third tranche of a share buyback programme. It details the financial parameters, the agreement with BNP Paribas, and the regulatory compliance for the repurchase of its own shares. This falls directly under the definition of 'Transaction in Own Shares' (POS), as it describes the company's activity in buying back its own shares from the market.
2025-09-30 English
GSK APPOINTS CEO DESIGNATE
Regulatory Filings
2025-09-29 English
GSK appoints CEO designate
Board/Management Information Classification · 100% confidence The document is an official announcement from GSK PLC regarding the appointment of a new CEO (Luke Miels) and the departure of the current CEO (Dame Emma Walmsley). It details the leadership transition, the appointment process, and the specific remuneration arrangements for both the incoming and outgoing executives. This content falls squarely under the definition of 'Board/Management Information' (MANG), which covers announcements of changes in senior management and board composition.
2025-09-29 English
DIRECTOR/PDMR SHAREHOLDING
Regulatory Filings
2025-09-22 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a formal notification of share purchases by Persons Discharging Managerial Responsibilities (PDMRs), specifically several Non-Executive Directors of GSK plc. It follows the standard regulatory format for reporting insider transactions, including details on the nature of the transaction, price, volume, and the identity of the directors involved. This aligns perfectly with the definition of a Director's Dealing (DIRS) filing.
2025-09-22 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.